Loading...
Images of Jérôme Berton
(0 from 0 )News
Analysis: Sanofi's cancer drug promising - UPI.com
www.upi.com
S-1 "should have a better benefit/risk ratio than (Roche's) Xeloda," Jerome Berton, an analyst with Aurel Leven, told United Press International.
Bristol-Myers hires banks for sale advice: sources | Reuters
www.reuters.com
... a friendly deal because its main risk lies in the execution of the merger, in a shock of cultures,” Aurel Leven analyst Jerome Berton said.
Market report: Astrazeneca put in spotlight as possible biotech...
www.telegraph.co.uk
Astrazeneca attracted attention as dealers speculated the drugs giant could be mulling a bid for Europe's largest biotechnology company Serono.
News Article - DDNewswww.ddn-news.com/index.php?newsarticle=3551
www.drugdiscoverynews.com
BASEL, Switzerland—Let's call Jérôme Berton the Nostradamus of ophthalmologic acquisitions, but let's not call Alcon Inc., the world's biggest eye-care ...
sorted by relevance / date